Hill, G E <br/><br/>
Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass.  [electronic resource] 

 -  Surgery  Apr 1997 
 - 449-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0039-6060 
<br/><br/><label>Standard No.: </label>10.1016/s0039-6060(97)90316-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aprotinin--pharmacology<br/>Blotting, Northern<br/>Cardiopulmonary Bypass<br/>Cell Line--drug effects<br/>Hemostatics--pharmacology<br/>Humans<br/>Immunohistochemistry<br/>Lung--drug effects<br/>Male<br/>Mice<br/>Nitric Oxide--biosynthesis<br/>Nitric Oxide Synthase--antagonists & inhibitors